Discover more insights into Dose Melphalan 도스 멜팔란

Keywords frequently search together with Dose Melphalan 도스 멜팔란

Narrow sentence examples with built-in keyword filters

Dose Melphalan sentence examples within autologous stem cell



Lessons in Long Term Survival from AL Amyloidosis


[Successful treatment of relapse/refractory multiple myeloma with carfilzomib, lenalidomide, and dexamethasone combination therapy following allogeneic bone marrow transplantation].

Dose Melphalan sentence examples within 200 mg m2



Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial


Dose-Intense BCNU/Melphalan Regimen Followed By Autologous Hematopoietic Cell Transplantation (AHCT) Results in Prolonged PFS in Myeloma Patients

Dose Melphalan sentence examples within autologous peripheral blood



Correlation of MicroRNA 17-92 Cluster Host Gene (MIR17HG) Polymorphisms With Susceptibility and Prognosis for Multiple Myeloma.


Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.


Learn more from Dose Melphalan 도스 멜팔란


Dose Melphalan sentence examples within stem cell transplantation



Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Time for an Obituary or Not Just Yet!


Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy

Dose Melphalan sentence examples within stem cell transplant



Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines

Dose Melphalan sentence examples within High Dose Melphalan



Lessons in Long Term Survival from AL Amyloidosis


New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Dose Melphalan sentence examples within dose melphalan followed



[Successful treatment of relapse/refractory multiple myeloma with carfilzomib, lenalidomide, and dexamethasone combination therapy following allogeneic bone marrow transplantation].


Efficacy of Chemotherapies and Stem Cell Transplantation for Systemic AL Amyloidosis: A Network Meta-Analysis

Dose Melphalan sentence examples within dose melphalan conditioning



Brachial plexopathy following autologous hematopoietic stem cell transplant: an unrecognized complication of autologous transplantation


Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

Dose Melphalan sentence examples within dose melphalan 200



Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma


Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

Dose Melphalan sentence examples within dose melphalan therapy



Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14)


Ixazomib-induced Sweet’s syndrome

Dose Melphalan sentence examples within dose melphalan chemotherapy



Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial.


Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma

Dose Melphalan sentence examples within dose melphalan plu



A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents


Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis.


Conditioning Regimen [High-Dose Melphalan (HDM) Versus an Alternative] May Impact Response in Patients (pts) with Relapsed Multiple Myeloma (rMM) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)


More Dose Melphalan 도스 멜팔란 sentence examples
10.1016/B978-0-323-56802-9.00017-1

Hematopoietic Cell Transplantation in Patients With Multiple Myeloma



Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.



Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma



Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure.



Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma



Taste Disturbance Evaluation Is Feasible and Higher Melphalan Pharmacokinetics Are Associated with Poorer Nutrition and Symptom Burden after Autologous HCT for Multiple Myeloma



High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients



[Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy].



Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor



Toxicity Analysis of Propylene Glycol-Free Melphalan (Evomela®) Compared to Propylene Glycol-Based Melphalan Hydrochloride in Autologous Hematopoietic Cell Transplantation for Multiple Myeloma



Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma



Pomalidomide in lenalidomide‐refractory multiple myeloma: Far from futile



Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells



Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Patients Receiving High-Dose Chemotherapy for Autologous Hematopoietic Stem Cell Transplantation (ASCT)



Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning



Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.



Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study.



The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation


Keywords related to Melphalan

Dose Melphalan 도스 멜팔란


Dose Melphalan 도스 멜팔란
Encyclopedia 백과사전